//www.floatpiers.com/ 2023-11-29T11:09:53.652Z //www.floatpiers.com/company 2023-12-22T16:41:22.007Z //www.floatpiers.com/company/about-us 2023-11-29T21:07:57.701Z //www.floatpiers.com/company/vision 2023-11-29T10:16:06.651Z //www.floatpiers.com/company/heritage 2023-11-29T10:16:06.653Z //www.floatpiers.com/company/we-are-global 2023-12-21T15:46:04.723Z //www.floatpiers.com/company/quality-commitment 2023-11-29T10:15:19.944Z //www.floatpiers.com/company/executive-leadership-team 2023-11-17T19:16:37.252Z //www.floatpiers.com/portfolio 2023-12-01T08:44:36.018Z //www.floatpiers.com/portfolio/pharma 2023-11-29T10:36:21.474Z //www.floatpiers.com/portfolio/nutrition 2023-11-29T10:36:21.475Z //www.floatpiers.com/portfolio/medtech 2023-12-22T15:57:10.66Z //www.floatpiers.com/portfolio/medtech/electronic-instructions-for-use-devices 2023-12-01T17:20:10.72Z //www.floatpiers.com/portfolio/biopharma 2023-12-22T15:58:52.854Z //www.floatpiers.com/responsibility 2023-12-22T15:53:34.113Z //www.floatpiers.com/responsibility/csr-agenda 2023-11-29T10:15:53.095Z //www.floatpiers.com/responsibility/employees 2023-11-29T10:15:42.445Z //www.floatpiers.com/responsibility/products-services 2023-11-29T10:15:42.444Z //www.floatpiers.com/responsibility/business-ethics 2023-11-29T11:09:28.464Z //www.floatpiers.com/responsibility/community 2023-11-29T10:15:42.444Z //www.floatpiers.com/responsibility/environment 2023-11-29T10:15:42.443Z //www.floatpiers.com/work-with-us 2023-11-29T10:05:42.807Z //www.floatpiers.com/work-with-us/why-us 2023-11-30T15:32:43.928Z //www.floatpiers.com/work-with-us/your-opportunities 2023-11-29T10:05:42.808Z //www.floatpiers.com/news-room 2023-12-20T07:49:14.411Z //www.floatpiers.com/news 2023-11-08T09:56:09.591Z //www.floatpiers.com/news/fresenius-kabi-launches-its-citrate-free-biosimilar-idacio 2023-11-18T09:52:20.222Z //www.floatpiers.com/news/fresenius-kabi-recognized-as-a-top-employer-in-2023 2023-11-18T09:43:27.452Z //www.floatpiers.com/news/virginia-oncology-associates-chooses-the-ivenix-infusion-system 2023-11-15T08:56:18.892Z //www.floatpiers.com/news/ustekinumab-biosimilar-ema-submission-acceptance 2023-11-12T09:49:43.221Z //www.floatpiers.com/news/jumpstart-clinical-nutrition-award-winner 2023-11-29T11:09:34.823Z //www.floatpiers.com/news/european-commission-approval-tyenne-tocilizumab-biosimilar 2023-11-18T09:41:38.704Z //www.floatpiers.com/news/paving-the-way-for-the-future-of-blood-transfusions 2023-11-18T09:45:47.433Z //www.floatpiers.com/news/fresenius-kabi-and-lupagen-enter-into-strategic-agreement 2023-11-18T09:45:13.601Z //www.floatpiers.com/news/fresenius-kabi-formycon-license-date-ustekinumab-biosimilar 2023-11-29T16:51:54.978Z //www.floatpiers.com/news/heroes-who-save-lives-thank-you-to-all-blood-and-plasma-donors 2023-11-29T11:09:34.825Z //www.floatpiers.com/news/the-gift-of-life-a-decision-to-donate-blood-or-plasma 2023-11-18T09:53:35.164Z //www.floatpiers.com/news/20230802-press-release-fse-q2-23 2023-11-29T10:16:58.732Z //www.floatpiers.com/news/fresenius-kabi-tocilizumab-biosimilar-candidate-msb11456 2023-11-12T09:20:56.315Z //www.floatpiers.com/news/fresenius-kabi-s-denosumab-biosimilar-candidate-fks518 2023-11-12T09:06:18.606Z //www.floatpiers.com/news/fresenius-se-hosts-kabi-capital-markets-day 2023-11-12T09:32:25.182Z //www.floatpiers.com/news/fresenius-kabi-awarded-technology-breakthrough-agreement-with-premier-inc 2023-11-18T10:00:22.799Z //www.floatpiers.com/news/biosimilar-candidate-tocilizumab-accepted-for-review-by-fda 2023-11-12T08:33:17.655Z //www.floatpiers.com/news/fresenius-kabi-buys-a-majority-stake-in-mabxience-and-acquires 2023-11-12T08:40:44.414Z //www.floatpiers.com/news/fresenius-kabi-receives-us-fda-approval-for-biosimilar 2023-11-18T09:55:12.34Z //www.floatpiers.com/news/europn-study-new-clinical-data-on-medical-nutrition-therapy 2023-11-11T08:47:18.969Z //www.floatpiers.com/news/fresenius-commits-to-support-earthquake-victims-in-turkiye-and-syria 2023-11-04T12:03:59.334Z //www.floatpiers.com/news/fresenius-kabi-at-the-euroanaesthesia-2023 2023-11-22T14:20:34.495Z //www.floatpiers.com/news/fresenius-kabi-completes-majority-stake-acquisition-of-mabxience 2023-11-11T09:02:31.245Z //www.floatpiers.com/news/fresenius-kabi-inaugurates-extension-of-production-facilities-in-dominican-republic 2023-11-04T12:15:17.298Z //www.floatpiers.com/news/fresenius-kabi-establishes-partnership-with-fiocruz-bio-manguinhos-bionovis 2023-11-18T09:56:07.891Z //www.floatpiers.com/news/fresenius-kabi-employees-team-up-for-breast-cancer-awareness 2023-11-05T08:48:12.719Z //www.floatpiers.com/news/fresenius-kabi-launches-biosimilar-stimufend-in-the-us 2023-11-18T09:58:20.11Z //www.floatpiers.com/news/fresenius-kabi-launches-single-needle-option-for-amicus-extracorporeal-photopheresis 2023-11-18T10:01:38.829Z //www.floatpiers.com/news/fresenius-kabi-offers-100-000-grant-to-advance-nutritional 2023-11-04T12:42:04.623Z //www.floatpiers.com/news/fresenius-kabi-prolongs-production-and-supply-contract-with-cerus 2023-11-12T11:14:53.052Z //www.floatpiers.com/news/fresenius-kabi-provides-humanitarian-aid-for-ukraine 2023-11-12T09:58:55.057Z //www.floatpiers.com/news/fresenius-kabi-tocilizumab-mma-accepted-by-ema 2023-11-05T09:05:46.863Z //www.floatpiers.com/news/further-donations-support-emergency-care-of-patients-ukraine 2023-11-12T09:52:29.302Z //www.floatpiers.com/news/international-day-of-women-in-science-interview-with-jumpstart-winner 2023-11-18T10:03:53.934Z //www.floatpiers.com/news/ivenix-infusion-system-is-recognized-by-klas-research 2023-11-18T10:05:00.634Z //www.floatpiers.com/news/ten-years-of-blood-donation-activity-across-china 2023-11-04T13:00:23.552Z //www.floatpiers.com/news/update-on-humanitarian-aid-for-ukraine 2023-11-12T09:55:36.422Z //www.floatpiers.com/news/vizient-innovative-technology-contract-awarded-fresenius-kabi 2023-11-18T10:02:44.18Z //www.floatpiers.com/news/waterproof-zip-toiletry-bag-wins-queen-silvia-nursing-award 2023-11-18T10:05:46.214Z //www.floatpiers.com/news/strong-development-of-the-operating-companies-in-q1-23 2023-11-29T10:16:58.731Z //www.floatpiers.com/news/new-appointments-to-the-management-board-at-fresenius 2023-11-10T16:14:04.879Z //www.floatpiers.com/news/fresenius-kabi-fiscal-year-2022-results-press-release 2023-11-29T10:16:58.731Z //www.floatpiers.com/news/business-report-third-quarter-of-2022-of-fresenius 2023-11-15T08:48:48.54Z //www.floatpiers.com/news/michael-sen-succeeds-former-fresenius-ceo-stephan-sturm 2023-11-04T13:26:38.062Z //www.floatpiers.com/news/business-report-second-quarter-and-first-half-of-2022 2023-11-04T13:27:05.715Z //www.floatpiers.com/news/revision-of-group-guidance-for-2022-by-fresenius 2023-11-10T16:17:07.556Z //www.floatpiers.com/news/business-report-first-quarter-2022-of-fresenius 2023-11-04T13:28:05.492Z //www.floatpiers.com/news/annual-report-2021-and-new-guidelines-for-fresenius 2023-11-04T13:28:32.343Z //www.floatpiers.com/news/help-for-communities-in-crisis 2023-11-29T11:09:34.824Z //www.floatpiers.com/news/jumpstart-2022-driving-research-in-clinical-nutrition 2023-11-29T11:09:34.823Z //www.floatpiers.com/news/learning-and-creativity-for-little-patients 2023-11-05T09:52:48.647Z //www.floatpiers.com/news/vision-2026-fresenius-kabi-healthy-growth-journey 2023-11-29T11:09:34.824Z //www.floatpiers.com/news/video-message-from-fresenius-ceo-michael-sen 2023-11-29T11:09:34.823Z //www.floatpiers.com/news/orf-film-plant-fresenius-kabi-austria 2023-11-12T10:12:31.657Z //www.floatpiers.com/news/global-license-agreement-fresenius-kabi-and-formycon-to-commercialize-ustekinumab-biosimilar 2023-11-04T14:01:13.801Z //www.floatpiers.com/news/fresenius-kabi-completes-acquisition-of-ivenix-inc 2023-11-01T15:45:45.861Z //www.floatpiers.com/news/fresenius-kabi-receives-ec-approval-for-pegfilgrastim-biosimilar-stimufend 2023-11-05T08:28:01.553Z //www.floatpiers.com/news/fresenius-kabi-receives-fda-approval-for-biosimilar-idacio 2023-11-12T08:30:00.429Z //www.floatpiers.com/news/gastrointestinal-dysfunction-study-wins-esicm-clinical-nutrition-award 2023-11-18T09:40:29.883Z //www.floatpiers.com/news/supporting-conscious-choices-in-nutritional-care 2023-11-18T09:39:24.086Z //www.floatpiers.com/news/fresenius-kabi-launches-tyenne-tocilizumab-biosimilar-eu 2023-11-04T14:19:06.325Z //www.floatpiers.com/news/press-release-fse-q3-2023 2023-11-29T10:16:58.731Z //www.floatpiers.com/news/our-commitment-to-fight-antimicrobial-resistance 2023-11-23T08:33:43.425Z //www.floatpiers.com/news/fda-submission-acceptance-ustekinumab-biosimilar 2023-11-30T06:29:18.491Z //www.floatpiers.com/news/fresenius-kabi-mayo-clinic-ivenix-agreement 2023-12-19T11:24:42.695Z //www.floatpiers.com/inspiring-stories 2023-11-06T13:02:48.545Z //www.floatpiers.com/inspiring-stories/living-on-parenteral-nutrition 2023-11-29T11:09:46.64Z //www.floatpiers.com/inspiring-stories/the-life-changing-application-at-fresenius-kabi 2023-11-29T10:14:42.155Z //www.floatpiers.com/inspiring-stories/growing-up-with-parenteral-nutrition 2023-11-29T10:14:42.153Z //www.floatpiers.com/inspiring-stories/i-want-to-help-others-so-they-won-t-give-up-living-on-parenteral 2023-11-29T10:14:42.158Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-biosimilars-cbs-news-video 2023-11-29T11:09:34.823Z //www.floatpiers.com/inspiring-stories/living-with-a-chronical-disease-a-patient-story 2023-11-29T11:09:46.639Z //www.floatpiers.com/inspiring-stories/nurses-our-real-life-heroes 2023-11-29T11:09:46.641Z //www.floatpiers.com/inspiring-stories/we-are-fresenius-kabi-with-a-true-purpose 2023-11-29T11:09:46.641Z //www.floatpiers.com/inspiring-stories/a-biosimilar-patient-story 2023-11-29T11:09:46.639Z //www.floatpiers.com/inspiring-stories/a-breakfast-tea-with-senanur-akkilic 2023-11-29T10:14:42.157Z //www.floatpiers.com/inspiring-stories/a-cup-of-chai-with-vaibhav-choudhary 2023-11-29T10:14:42.157Z //www.floatpiers.com/inspiring-stories/a-black-coffee-with-afef-ftouhi-plant-manager 2023-11-29T10:14:42.15Z //www.floatpiers.com/inspiring-stories/a-cup-of-black-tea-with-iris-brujan 2023-11-29T10:14:42.156Z //www.floatpiers.com/inspiring-stories/a-hot-chocolate-with-stephane-nonche 2023-11-29T10:14:42.153Z //www.floatpiers.com/inspiring-stories/two-cups-of-cappuccino-with-simone-and-maximilian 2023-11-29T10:14:42.147Z //www.floatpiers.com/inspiring-stories/earl-grey-with-evelina-saievych-caring-for-life 2023-11-29T10:14:42.156Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-employee-received-excellent-instructor-award 2023-11-29T10:14:42.158Z //www.floatpiers.com/inspiring-stories/joining-forces-to-fight-pollution 2023-11-29T10:14:42.157Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-home-artificial-nutrition-improves-patients-quality-of-life 2023-11-29T10:14:42.152Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-home-artificial-nutrition-improves-patients-quality-of-life/amys-story 2023-11-29T10:13:45.495Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-home-artificial-nutrition-improves-patients-quality-of-life/nathalies-story 2023-11-29T10:13:45.491Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-home-artificial-nutrition-improves-patients-quality-of-life/pauls-story 2023-11-29T10:13:45.496Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-home-artificial-nutrition-improves-patients-quality-of-life/toms-story 2023-11-29T10:13:45.495Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-home-artificial-nutrition-improves-patients-quality-of-life/emmas-story 2023-11-29T10:13:45.495Z //www.floatpiers.com/inspiring-stories/fresenius-kabi-swissbiosim-spreads-smiles-and-happiness 2023-11-29T10:14:42.154Z //www.floatpiers.com/inspiring-stories/living-life-to-the-fullest-thanks-to-artificial-nutrition 2023-11-29T10:14:42.156Z //www.floatpiers.com/inspiring-stories/partnering-for-european-medicines-resilience 2023-11-29T10:14:42.157Z //www.floatpiers.com/inspiring-stories/a-glass-of-orange-juice-with-vinaydutt 2023-12-05T08:53:41.431Z //www.floatpiers.com/resource-center 2023-11-17T19:58:27.208Z kok体育是什么//www.floatpiers.com/contact 2023-11-17T19:59:18.626Z //www.floatpiers.com/data-protection 2023-11-17T20:00:45.315Z //www.floatpiers.com/results 2023-11-15T17:06:05.874Z //www.floatpiers.com/errors 2023-11-20T12:02:24.724Z //www.floatpiers.com/errors/404 2023-11-20T12:02:31.939Z //www.floatpiers.com/sap-ariba 2023-11-18T09:10:37.827Z